Exagen Agrees to Pay Over $650K to Resolve Kickback Allegations
17 Outubro 2023 - 3:50PM
Dow Jones News
By Denny Jacob
Exagen agreed to pay $650,143 to resolve allegations it paid
specimen processing fees to referring physicians to induce their
use of the company's laboratory tests.
The commercial-stage diagnostics company agreed to factual
admissions that it paid certain referring physicians to complete
blood draws for patients in connection to specimen processing
agreements that Exagen entered into with those physicians,
according to the Department of Justice.
Exagen billed federal healthcare programs, including Medicare,
for tests it performed after receiving orders from the physicians,
according to the settlement. The company did so even after becoming
aware of a fraud alert in June from the Department of Health &
Human Services' Office of the Inspector General.
DOJ said the settlement stems from allegations brought in a
lawsuit filed by a whistleblower, who will receive 16% of the
recovered settlement.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
October 17, 2023 14:35 ET (18:35 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Exagen (NASDAQ:XGN)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Exagen (NASDAQ:XGN)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024